InnovAge Holding Corp. (INNV) stock
INNVNasdaqServices-Health ServicesFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 11/3066% above fair value
$9.58+0.11 (+1.16%)
Close on Nov 16, 2026Market cap $1.31BP/E –Yield –
InnovAge cash
Cash and short-term investments held at the end of each period.
InnovAge's cash was $141.33M at Jun 30, 2026. For fiscal 2026 it was $141.33M, up 33.4% from the year before. The highest annual figure on record is $203.70M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Jun 30, 2026 | $141.33M | +33.4% |
| FY2025 | Jun 30, 2025 | $105.90M | +3.0% |
| FY2024 | Jun 30, 2024 | $102.79M | -40.7% |
| FY2023 | Jun 30, 2023 | $173.48M | -5.9% |
| FY2022 | Jun 30, 2022 | $184.45M | -9.5% |
| FY2021 | Jun 30, 2021 | $203.70M | +77.8% |
| FY2020 | Jun 30, 2020 | $114.57M | +87.2% |
| FY2019 | Jun 30, 2019 | $61.20M | – |
Quarterly cash
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2026CQ2 2026 | Jun 30, 2026 | $141.33M | +33.4% |
| Q3 FY2026CQ1 2026 | Mar 31, 2026 | $138.59M | +36.2% |
| Q2 FY2026CQ4 2025 | Dec 31, 2025 | $125.96M | +45.0% |
| Q1 FY2026CQ3 2025 | Sep 30, 2025 | $109.42M | +27.7% |
| Q4 FY2025CQ2 2025 | Jun 30, 2025 | $105.90M | +3.0% |
| Q3 FY2025CQ1 2025 | Mar 31, 2025 | $101.75M | +2.4% |
| Q2 FY2025CQ4 2024 | Dec 31, 2024 | $86.87M | -12.1% |
| Q1 FY2025CQ3 2024 | Sep 30, 2024 | $85.69M | -36.6% |
| Q4 FY2024CQ2 2024 | Jun 30, 2024 | $102.79M | -40.7% |
| Q3 FY2024CQ1 2024 | Mar 31, 2024 | $99.34M | -40.7% |
| Q2 FY2024CQ4 2023 | Dec 31, 2023 | $98.79M | -31.8% |
| Q1 FY2024CQ3 2023 | Sep 30, 2023 | $135.25M | -28.2% |
| Q4 FY2023CQ2 2023 | Jun 30, 2023 | $173.48M | -5.9% |
| Q3 FY2023CQ1 2023 | Mar 31, 2023 | $167.57M | -16.0% |
| Q2 FY2023CQ4 2022 | Dec 31, 2022 | $144.90M | -33.7% |
| Q1 FY2023CQ3 2022 | Sep 30, 2022 | $188.24M | -13.6% |
| Q4 FY2022CQ2 2022 | Jun 30, 2022 | $184.45M | -9.5% |
| Q3 FY2022CQ1 2022 | Mar 31, 2022 | $199.51M | -2.1% |
| Q2 FY2022CQ4 2021 | Dec 31, 2021 | $218.55M | +176.7% |
| Q1 FY2022CQ3 2021 | Sep 30, 2021 | $217.77M | +319.8% |
| Q4 FY2021CQ2 2021 | Jun 30, 2021 | $203.70M | +77.8% |
| Q3 FY2021CQ1 2021 | Mar 31, 2021 | $203.76M | +112.0% |
| Q2 FY2021CQ4 2020 | Dec 31, 2020 | $78.99M | +29.1% |
| Q1 FY2021CQ3 2020 | Sep 30, 2020 | $51.88M | +476.4% |
| Q4 FY2020CQ2 2020 | Jun 30, 2020 | $114.57M | – |
| Q3 FY2020CQ1 2020 | Mar 31, 2020 | $96.13M | – |
| Q4 FY2019CQ2 2019 | Jun 30, 2019 | $61.20M | – |
| Q3 FY2019CQ1 2019 | Mar 18, 2019 | $9.00M | – |
See a number that looks wrong?